Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.11) per share which missed the analyst consensus estimate of $(0.80) by 163.75 percent. This is a 211.05 percent decrease over earnings of $1.90 per share from the same period last year. The company reported quarterly sales of $1.100 million which missed the analyst consensus estimate of $1.600 million by 31.25 percent. This is a 8.33 percent decrease over sales of $1.200 million the same period last year.